References
- Stimson GV, Alldritt L, Dolan K, Donoghoe MC. Syringe-exchange schemes in England and Scotland. Br Med J 1988; 296: 1717–1717
- Donoghoe MC. Syringe-exchange: has it worked?. Druglink Jan/Feb, 1991; 8–11
- Stimson GV, Alldritt LJ, Dolan KA, Donoghoe MC, Lart RA. Injecting equipment exchange schemes. Final report2nd edn. The Centre for Research on Drugs and Health Behaviour, London 1992
- Stimson GV, Donoghoe MC, Lart R, Dolan K. Distributing sterile needles and syringes to people who inject drugs: the syringe-exchange experiment. AIDS and Drug Misuse, J Strang, G Stimson. Routledge, London 1990; 222–231, In
- Hart G, Woodward N, Carvell A. Needle-Exchange in Central London: operating philosophy and communication strategies. AIDS Care 1989; 1(2)125–134
- Brettle, RP, Davison, J, Davidson, SJ, et al. HTLV-III antibodies in an Edinburgh clinic. Lancet 1986; i: 1099–1099
- Robert, CF, Deglon, JJ, Wintsch, J, Martin, JL, et al. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980–1989. AIDS 1990; 4: 657–660
- Paine S, Tonuma M, Monheit B. AIDS in drug abusers. Med J Aust 1985; 143: 631–631
- Lungley S. Intravenous drug use in New Zealand: a baseline study of intravenous drug users and their risk of AIDS. Health Services Research and Development Unit, Wellington 1988
- Espinoza P, Bouchard I, Ballian P, Devoto JP. Has the open sale of syringes modified syringe exchanging habits of drug addicts?. IV International Conference on AIDS, Stockholm, 1988
- Sheehan M, Oppenheimer E, Taylor C. Who comes for treatment: drug misusers at three London agencies. Br J Addict 1988; 82: 311–320
- Mulleady G, Green J. Syringe sharing among London drug abusers. Lancet 1985; ii: 1425–1425
- Donoghoe MC, Dolan KA, Stimson GV. Changes in injectors' HIV risk behaviour and syringe supply in UK 1987–90. VII International Conference on AIDS, Florence, 1991; 45, TH.C.
- Buning E. The role of harm reduction programmes in curbing the spread of HIV by drug injectors. AIDS and Drug Misuse, J Strang, GV Stimson. Routledge, London 1991; 153–161, In
- Lungley S, Baker M. The needle and syringe-exchange scheme in operation an evaluation of the first year. Department of Health—Te Tari Ora, Wellington 1990
- Wolk J, Wodak A, Guinan JJ, Macaskill P, Simpson JM. The effect of a needle and syringe-exchange on a methadone maintenance unit. Br J Addict 1990; 85: 1445–1450
- Ljunberg, B, Christensson, B, Tunving, K, et al. HIV prevention among injecting drug users: three years of experience from a syringe-exchange program in Sweden. J AIDS 1991; 4: 890–895
- Watters J, Cheng Yu-Teh. Syringe-exchange (SE) in San Francisco: Preliminary findings. VII International Conference on AIDS, Florence, June, 1991; 99, TH.C.
- Hagan H, Des Jarlais DC, Purchase D, Reid TR, Friedman SR. Lower HIV Seroprevalence, declining HBV and safer injection in relation to the Tacoma syringe-exchange. VII International Conference on AIDS, Florence, June, 1991
- Watters, JK, Cheng, Y, Segal, M, Lorvick, J, et al. Epidemiology and prevention of HIV in intravenous drug users in San Francisco. VI International Conference on AIDS VI International Conference on AIDSSan FranciscoVI International Conference on AIDSSan FranciscoJune, 1990
- Battjes RJ, Pickens R, Amsel Z. Trends in HIV infection and AIDS risk behaviors among intravenous drug users in selected US cities. VII International Conference on AIDS, Florence, June, 1991; 46, TH.C.
- Klee H, Faugier J, Hayes C, Morris J. The sharing of injecting equipment among drug users attending prescribing clinics and those using needle-exchanges. Br J Addict 1991; 86: 217–223
- Mulleady G, Sherr L. Lifestyle factors for drug users in relation to risk for HIV. AIDS Care 1989; 1: 45–50
- Robertson JR, Skidmore CA, Roberts JK. HIV infection in intravenous drug users: a follow up study indicating changes in risk taking behaviour. Br J Addict 1988; 83: 387–391
- Donoghoe MC, Stimson GV, Dolan K. Sexual behaviour of injecting drug users and associated risks of HIV infection for non-injecting sexual partners. AIDS Care 1989; 1: 51–58
- Haw, S, Frischer, M, Donoghoe, MC, et al. The importance of multi-site sampling in determining the prevalence of HIV infection among drug injectors in Glasgow and London. AIDS 1992; 6: 517–518
- Turnbull PJ, Dolan KA, Stimson GV. HIV, AIDS and prison: risks and experiences in custodial care. AVERT, HorshamEngland 1991
- Hart GJ, Carvell ALM, Woodward N, Johnson AM, Williams P, Parry JV. Evaluation of needle exchange in central London: behaviour change and anti-HIV status over one year. AIDS 1989; 3: 261–265
- Johnson AM, Parry JV, Best SJ, Smith AM, de Silva M, Mortimer PP. HIV surveillance by testing saliva. AIDS 1988; 2: 369–371
- Metzger, DS, Woody, GE, Watkins, KE, et al. Risk behaviours and seroconversion among intravenous drug users in and out of treatment. VII International Conference on AIDS VII International Conference on AIDSFlorenceVII International Conference on AIDSFlorenceJune, 1991, WC3320
- Donoghoe MC, Rhodes TJ, Hunter GM, Stimson GV. HIV testing and unreported HIV positivity among injecting drug users in London. AIDS 1993, in press
- Griffiths P, Powis B, Strang J, Gossop M. Extent and nature of transitions of route among heroin addicts in treatment—preliminary data from the drug transitions study. Br J Addict 1992; 87(3)473–483
- Stimson GV, Oppenheimer E. Heroin addiction: treatment and control in Britain. Tavistock, London 1982
- Battjes R, Pickens R. Trends in HIV infection and AIDS risk behaviors among intravenous drug users in selected US cities. VIII International Conference on AIDS, Amsterdam, July, 1992, PoC4247